CN102935130A - 一种提高缺氧耐受力的中药组合物及其制备方法和应用 - Google Patents
一种提高缺氧耐受力的中药组合物及其制备方法和应用 Download PDFInfo
- Publication number
- CN102935130A CN102935130A CN2012105234904A CN201210523490A CN102935130A CN 102935130 A CN102935130 A CN 102935130A CN 2012105234904 A CN2012105234904 A CN 2012105234904A CN 201210523490 A CN201210523490 A CN 201210523490A CN 102935130 A CN102935130 A CN 102935130A
- Authority
- CN
- China
- Prior art keywords
- chinese medicine
- medicine composition
- parts
- preparation
- anoxia endurance
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 47
- 206010021143 Hypoxia Diseases 0.000 title claims abstract description 27
- 239000000203 mixture Substances 0.000 title claims abstract description 26
- 206010002660 Anoxia Diseases 0.000 title claims abstract description 24
- 241000976983 Anoxia Species 0.000 title claims abstract description 24
- 230000007953 anoxia Effects 0.000 title claims abstract description 24
- 238000002360 preparation method Methods 0.000 title claims abstract description 22
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 40
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 27
- 239000007788 liquid Substances 0.000 claims abstract description 11
- 244000207032 American speedwell Species 0.000 claims abstract description 5
- 238000001694 spray drying Methods 0.000 claims abstract description 5
- 239000012567 medical material Substances 0.000 claims description 21
- 241000756943 Codonopsis Species 0.000 claims description 15
- 241000237903 Hirudo Species 0.000 claims description 15
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 15
- 239000009636 Huang Qi Substances 0.000 claims description 13
- 239000000706 filtrate Substances 0.000 claims description 12
- 239000002775 capsule Substances 0.000 claims description 10
- 239000002671 adjuvant Substances 0.000 claims description 9
- 239000008187 granular material Substances 0.000 claims description 9
- 239000002994 raw material Substances 0.000 claims description 7
- 238000003756 stirring Methods 0.000 claims description 7
- 239000007921 spray Substances 0.000 claims description 5
- 239000003826 tablet Substances 0.000 claims description 5
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 4
- 229930006000 Sucrose Natural products 0.000 claims description 4
- 239000005720 sucrose Substances 0.000 claims description 4
- 229920001353 Dextrin Polymers 0.000 claims description 3
- 239000004375 Dextrin Substances 0.000 claims description 3
- 229920002472 Starch Polymers 0.000 claims description 3
- 235000019425 dextrin Nutrition 0.000 claims description 3
- 239000008107 starch Substances 0.000 claims description 3
- 235000019698 starch Nutrition 0.000 claims description 3
- LNAZSHAWQACDHT-XIYTZBAFSA-N (2r,3r,4s,5r,6s)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2s,3r,4s,5r,6r)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6r)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 claims description 2
- 229920002134 Carboxymethyl cellulose Polymers 0.000 claims description 2
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 claims description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 2
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 claims description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 2
- 229920000168 Microcrystalline cellulose Polymers 0.000 claims description 2
- 241000545442 Radix Species 0.000 claims description 2
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 claims description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 2
- 238000004364 calculation method Methods 0.000 claims description 2
- 239000001768 carboxy methyl cellulose Substances 0.000 claims description 2
- 235000010948 carboxy methyl cellulose Nutrition 0.000 claims description 2
- 239000008112 carboxymethyl-cellulose Substances 0.000 claims description 2
- 230000006837 decompression Effects 0.000 claims description 2
- 239000008103 glucose Substances 0.000 claims description 2
- 239000001863 hydroxypropyl cellulose Substances 0.000 claims description 2
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 claims description 2
- 239000008101 lactose Substances 0.000 claims description 2
- 238000000034 method Methods 0.000 claims description 2
- 229920000609 methyl cellulose Polymers 0.000 claims description 2
- 239000001923 methylcellulose Substances 0.000 claims description 2
- 235000010981 methylcellulose Nutrition 0.000 claims description 2
- 235000019813 microcrystalline cellulose Nutrition 0.000 claims description 2
- 239000008108 microcrystalline cellulose Substances 0.000 claims description 2
- 229940016286 microcrystalline cellulose Drugs 0.000 claims description 2
- 229940013618 stevioside Drugs 0.000 claims description 2
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 claims description 2
- 235000019202 steviosides Nutrition 0.000 claims description 2
- 239000000284 extract Substances 0.000 abstract description 4
- 240000001899 Murraya exotica Species 0.000 abstract description 2
- 235000008766 Murraya exotica Nutrition 0.000 abstract description 2
- 241000159213 Zygophyllaceae Species 0.000 abstract description 2
- 239000000463 material Substances 0.000 abstract description 2
- MUKYLHIZBOASDM-UHFFFAOYSA-N 2-[carbamimidoyl(methyl)amino]acetic acid 2,3,4,5,6-pentahydroxyhexanoic acid Chemical compound NC(=N)N(C)CC(O)=O.OCC(O)C(O)C(O)C(O)C(O)=O MUKYLHIZBOASDM-UHFFFAOYSA-N 0.000 abstract 1
- 241000134125 Asplenium antiquum Species 0.000 abstract 1
- 241000045403 Astragalus propinquus Species 0.000 abstract 1
- 241000459479 Capsula Species 0.000 abstract 1
- 241000007126 Codonopsis pilosula Species 0.000 abstract 1
- 235000009696 Murraya paniculata Nutrition 0.000 abstract 1
- 235000006533 astragalus Nutrition 0.000 abstract 1
- 239000002245 particle Substances 0.000 abstract 1
- 239000000843 powder Substances 0.000 abstract 1
- 238000001556 precipitation Methods 0.000 abstract 1
- 235000009165 saligot Nutrition 0.000 abstract 1
- 229940079593 drug Drugs 0.000 description 16
- 230000000694 effects Effects 0.000 description 15
- 241000382414 Veronica peregrina Species 0.000 description 13
- 241000699670 Mus sp. Species 0.000 description 12
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 11
- 229910052760 oxygen Inorganic materials 0.000 description 11
- 239000001301 oxygen Substances 0.000 description 11
- 230000002929 anti-fatigue Effects 0.000 description 8
- 239000008280 blood Substances 0.000 description 7
- 210000004369 blood Anatomy 0.000 description 7
- 230000001737 promoting effect Effects 0.000 description 6
- 230000017531 blood circulation Effects 0.000 description 5
- 238000004064 recycling Methods 0.000 description 5
- 239000001913 cellulose Substances 0.000 description 4
- 229920002678 cellulose Polymers 0.000 description 4
- 235000010980 cellulose Nutrition 0.000 description 4
- 230000003203 everyday effect Effects 0.000 description 4
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 4
- 239000010931 gold Substances 0.000 description 4
- 229910052737 gold Inorganic materials 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 240000004435 Asplenium nidus Species 0.000 description 3
- 235000014256 Asplenium nidus Nutrition 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- ODINCKMPIJJUCX-UHFFFAOYSA-N Calcium oxide Chemical compound [Ca]=O ODINCKMPIJJUCX-UHFFFAOYSA-N 0.000 description 2
- 241000721047 Danaus plexippus Species 0.000 description 2
- 206010013786 Dry skin Diseases 0.000 description 2
- 206010038669 Respiratory arrest Diseases 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000003304 gavage Methods 0.000 description 2
- 230000007954 hypoxia Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000002503 metabolic effect Effects 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 230000036284 oxygen consumption Effects 0.000 description 2
- 230000029058 respiratory gaseous exchange Effects 0.000 description 2
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 2
- 235000010234 sodium benzoate Nutrition 0.000 description 2
- 239000004299 sodium benzoate Substances 0.000 description 2
- 239000007779 soft material Substances 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 229940099259 vaseline Drugs 0.000 description 2
- 238000009423 ventilation Methods 0.000 description 2
- 241000134854 Aspleniaceae Species 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000201295 Euphrasia Species 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 206010048612 Hydrothorax Diseases 0.000 description 1
- 238000012449 Kunming mouse Methods 0.000 description 1
- 102000010445 Lactoferrin Human genes 0.000 description 1
- 108010063045 Lactoferrin Proteins 0.000 description 1
- 208000019693 Lung disease Diseases 0.000 description 1
- 206010027423 Metabolic alkalosis Diseases 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- 241000013557 Plantaginaceae Species 0.000 description 1
- 241001529246 Platymiscium Species 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 206010037423 Pulmonary oedema Diseases 0.000 description 1
- 208000004756 Respiratory Insufficiency Diseases 0.000 description 1
- 241001093501 Rutaceae Species 0.000 description 1
- 241001533104 Tribulus terrestris Species 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000001139 anti-pruritic effect Effects 0.000 description 1
- 239000003908 antipruritic agent Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 208000003532 hypothyroidism Diseases 0.000 description 1
- 230000002989 hypothyroidism Effects 0.000 description 1
- 208000018875 hypoxemia Diseases 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- CSSYQJWUGATIHM-IKGCZBKSSA-N l-phenylalanyl-l-lysyl-l-cysteinyl-l-arginyl-l-arginyl-l-tryptophyl-l-glutaminyl-l-tryptophyl-l-arginyl-l-methionyl-l-lysyl-l-lysyl-l-leucylglycyl-l-alanyl-l-prolyl-l-seryl-l-isoleucyl-l-threonyl-l-cysteinyl-l-valyl-l-arginyl-l-arginyl-l-alanyl-l-phenylal Chemical compound C([C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 CSSYQJWUGATIHM-IKGCZBKSSA-N 0.000 description 1
- 229940078795 lactoferrin Drugs 0.000 description 1
- 235000021242 lactoferrin Nutrition 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- 201000003144 pneumothorax Diseases 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 208000005333 pulmonary edema Diseases 0.000 description 1
- 201000004193 respiratory failure Diseases 0.000 description 1
- 210000003019 respiratory muscle Anatomy 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
黄芪 | 仙桃草 | 党参 | 蒺藜 | 铁蚂蝗 | 九里香 | |
实施例1 | 30 | 20 | 25 | 10 | 30 | 10 |
实施例2 | 20 | 30 | 20 | 20 | 20 | 20 |
实施例3 | 10 | 40 | 15 | 30 | 10 | 30 |
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210523490.4A CN102935130B (zh) | 2012-12-08 | 2012-12-08 | 一种提高缺氧耐受力的中药组合物及其制备方法和应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210523490.4A CN102935130B (zh) | 2012-12-08 | 2012-12-08 | 一种提高缺氧耐受力的中药组合物及其制备方法和应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102935130A true CN102935130A (zh) | 2013-02-20 |
CN102935130B CN102935130B (zh) | 2014-03-19 |
Family
ID=47694077
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210523490.4A Expired - Fee Related CN102935130B (zh) | 2012-12-08 | 2012-12-08 | 一种提高缺氧耐受力的中药组合物及其制备方法和应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102935130B (zh) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105767219A (zh) * | 2016-03-11 | 2016-07-20 | 李正梅 | 一种植物油的制备方法及植物油制品 |
CN106616595A (zh) * | 2016-11-16 | 2017-05-10 | 新乡医学院 | 一种强抗氧化抗缺氧的保健食品制剂及应用 |
CN106913763A (zh) * | 2015-12-25 | 2017-07-04 | 张�杰 | 一种可提高高原缺氧耐受力的生物复合制剂 |
WO2017185280A1 (zh) * | 2016-04-28 | 2017-11-02 | 金英花 | 一种可提高高原缺氧耐受力的生物复合制剂及其制备方法 |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104398754A (zh) * | 2014-11-07 | 2015-03-11 | 朱海燕 | 一种提高缺氧耐受力的中药组合物及其制备方法和应用 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1523988A1 (en) * | 2003-04-29 | 2005-04-20 | Li Min Pharmaceutical Factory of Livzon Pharmaceutical | A composition containing radix codonopsis pilosulae and radix astragali and hedysari, method of producing it and use thereof |
WO2007026201A1 (en) * | 2005-09-01 | 2007-03-08 | Council Of Scientific And Industrial Research | A pharmaceutical composition useful for the treatment of prostate cancer |
CN102614281A (zh) * | 2012-04-23 | 2012-08-01 | 卞毓平 | 一种提高缺氧耐受力的中药组合物及其制备方法和应用 |
-
2012
- 2012-12-08 CN CN201210523490.4A patent/CN102935130B/zh not_active Expired - Fee Related
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1523988A1 (en) * | 2003-04-29 | 2005-04-20 | Li Min Pharmaceutical Factory of Livzon Pharmaceutical | A composition containing radix codonopsis pilosulae and radix astragali and hedysari, method of producing it and use thereof |
WO2007026201A1 (en) * | 2005-09-01 | 2007-03-08 | Council Of Scientific And Industrial Research | A pharmaceutical composition useful for the treatment of prostate cancer |
CN102614281A (zh) * | 2012-04-23 | 2012-08-01 | 卞毓平 | 一种提高缺氧耐受力的中药组合物及其制备方法和应用 |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106913763A (zh) * | 2015-12-25 | 2017-07-04 | 张�杰 | 一种可提高高原缺氧耐受力的生物复合制剂 |
CN105767219A (zh) * | 2016-03-11 | 2016-07-20 | 李正梅 | 一种植物油的制备方法及植物油制品 |
WO2017185280A1 (zh) * | 2016-04-28 | 2017-11-02 | 金英花 | 一种可提高高原缺氧耐受力的生物复合制剂及其制备方法 |
CN106616595A (zh) * | 2016-11-16 | 2017-05-10 | 新乡医学院 | 一种强抗氧化抗缺氧的保健食品制剂及应用 |
Also Published As
Publication number | Publication date |
---|---|
CN102935130B (zh) | 2014-03-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101513437B (zh) | 一种抗疲劳中药组合物及其制备方法 | |
CN102935130B (zh) | 一种提高缺氧耐受力的中药组合物及其制备方法和应用 | |
CN102614281B (zh) | 一种提高缺氧耐受力的中药组合物及其制备方法和应用 | |
CN102120015A (zh) | 一种用于舒肝解郁、安神定志的中药及制法和质量标准 | |
CN103110846B (zh) | 一种用于治疗高脂血症的中药组合物及其制备方法和应用 | |
CN102475830B (zh) | 一种治疗冠心病心绞痛的药物组合物与其制备方法及制剂 | |
CN102940851A (zh) | 一种用于颈椎病的中药分散片及其制备方法 | |
CN102266452A (zh) | 一种提高缺氧耐受力的中药组合物及其制备方法和应用 | |
CN102961584B (zh) | 一种抗疲劳的中药组合物及其制备方法和应用 | |
CN102258680A (zh) | 一种缓解体力疲劳的中药组合物及其制备方法和应用 | |
CN101049429A (zh) | 一种用于妇科的调经祛斑片及其制备方法 | |
CN104013733B (zh) | 一种防治化学性肝损伤的壳聚糖组合物及其制备方法 | |
CN102614280B (zh) | 一种具有降低血脂功效的中药组合物及其制备方法和应用 | |
CN105663204A (zh) | 一种具有提高免疫功能、抗疲劳、治疗感冒的组合物和制剂及其制备方法和用途 | |
CN101628059B (zh) | 一种药物组合物和含有该药物组合物的药物制剂 | |
CN102626510B (zh) | 一种治疗糖尿病心脏病的中药组合物及其制备方法和应用 | |
CN104857143A (zh) | 一种提高缺氧耐受力的药物制剂 | |
CN103919845B (zh) | 一种提高缺氧耐受力的药物组合物及其制备方法和应用 | |
CN103494916B (zh) | 一种具有降低血糖功效的中药组合物及其制备方法和应用 | |
CN102614372A (zh) | 一种抗疲劳的中药组合物及其制备方法和应用 | |
CN105125898A (zh) | 一种含黄芪和天麻具有益气补血的药物制剂 | |
CN103494894A (zh) | 一种具有降低血糖功效的中药组合物及其制备方法和应用 | |
CN1294948C (zh) | 一种益气健脾滋补肝肾的药物及其制备方法 | |
CN103919972B (zh) | 一种抗疲劳的药物组合物及其制备方法和应用 | |
CN103989894A (zh) | 一种提高缺氧耐受力的含片及其制备方法和应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: XINXIANG MEDICAL UNIVERSITY Free format text: FORMER OWNER: NANJING ZHENGKUAN PHARMACEUTICAL SCIENCE AND TECHNOLOGY CO., LTD. Effective date: 20140213 |
|
CB03 | Change of inventor or designer information | ||
CB03 | Change of inventor or designer information |
Inventor after: Niu Jie Inventor after: Wu Junfang Inventor after: Li Xiaopeng Inventor after: Han Xiaohong Inventor after: Du Yunhong Inventor after: Xu Na Inventor after: Guo Zhigang Inventor after: Wang Yanli Inventor after: Qiu Lele Inventor before: The inventor has waived the right to be mentioned |
|
COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: REQUEST NOT TO RELEASE THE NAME TO: NIU JIE WU JUNFANG LI XIAOPENG HAN XIAOHONG DU YUNHONG XU NA GUO ZHIGANG WANG YANLI QIU LELE Free format text: CORRECT: ADDRESS; FROM: 211224 NANJING, JIANGSU PROVINCE TO: 453003 XINXIANG, HENAN PROVINCE |
|
TA01 | Transfer of patent application right |
Effective date of registration: 20140213 Address after: No. 601 Xinxiang City, Henan province Jinsui road 453003 Applicant after: Xinxiang Medical College Address before: 211224 No. 1 Industrial Park, Jing Qiao Town, Lishui County, Jiangsu, Nanjing Applicant before: Nanjing Zhengkuan Pharmaceutical Science and Technology Co., Ltd. |
|
TA01 | Transfer of patent application right | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20140319 Termination date: 20141208 |
|
EXPY | Termination of patent right or utility model |